These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

358 related articles for article (PubMed ID: 27212125)

  • 1. Prostate cancer epigenetics and its clinical implications.
    Yegnasubramanian S
    Asian J Androl; 2016; 18(4):549-58. PubMed ID: 27212125
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Prostate Cancer Epigenetics: From Basic Mechanisms to Clinical Implications.
    Yegnasubramanian S; De Marzo AM; Nelson WG
    Cold Spring Harb Perspect Med; 2019 Apr; 9(4):. PubMed ID: 29959132
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The expanding role of epigenetics in the development, diagnosis and treatment of prostate cancer and benign prostatic hyperplasia.
    Dobosy JR; Roberts JL; Fu VX; Jarrard DF
    J Urol; 2007 Mar; 177(3):822-31. PubMed ID: 17296351
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Epigenetics of prostate cancer].
    Yi XM; Zhou WQ
    Zhonghua Nan Ke Xue; 2010 Jul; 16(7):635-41. PubMed ID: 20873600
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Exploiting Epigenetic Alterations in Prostate Cancer.
    Baumgart SJ; Haendler B
    Int J Mol Sci; 2017 May; 18(5):. PubMed ID: 28486411
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Epigenetics of prostate cancer.
    Li LC
    Front Biosci; 2007 May; 12():3377-97. PubMed ID: 17485307
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Epigenetics in prostate cancer: biologic and clinical relevance.
    Jerónimo C; Bastian PJ; Bjartell A; Carbone GM; Catto JW; Clark SJ; Henrique R; Nelson WG; Shariat SF
    Eur Urol; 2011 Oct; 60(4):753-66. PubMed ID: 21719191
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Epigenetic Modifications and Modulators in Prostate Cancer.
    Cimadamore A; Gasparrini S; Scarpelli M; Doria A; Mazzucchelli R; Massari F; Cheng L; Lopez-Beltran A; Montironi R
    Crit Rev Oncog; 2017; 22(5-6):439-450. PubMed ID: 29604923
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Epigenetic regulation of prostate cancer: the theories and the clinical implications.
    Liao Y; Xu K
    Asian J Androl; 2019; 21(3):279-290. PubMed ID: 30084432
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Abnormal DNA methylation, epigenetics, and prostate cancer.
    Nelson WG; Yegnasubramanian S; Agoston AT; Bastian PJ; Lee BH; Nakayama M; De Marzo AM
    Front Biosci; 2007 May; 12():4254-66. PubMed ID: 17485372
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The association between histone 3 lysine 27 trimethylation (H3K27me3) and prostate cancer: relationship with clinicopathological parameters.
    Ngollo M; Lebert A; Dagdemir A; Judes G; Karsli-Ceppioglu S; Daures M; Kemeny JL; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon D
    BMC Cancer; 2014 Dec; 14():994. PubMed ID: 25535400
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Epigenetic modifications in prostate cancer.
    Ngollo M; Dagdemir A; Karsli-Ceppioglu S; Judes G; Pajon A; Penault-Llorca F; Boiteux JP; Bignon YJ; Guy L; Bernard-Gallon DJ
    Epigenomics; 2014; 6(4):415-26. PubMed ID: 25333850
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Epigenetic changes in prostate cancer: implication for diagnosis and treatment.
    Li LC; Carroll PR; Dahiya R
    J Natl Cancer Inst; 2005 Jan; 97(2):103-15. PubMed ID: 15657340
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Epigenetic targets in the diagnosis and treatment of prostate cancer.
    Manoharan M; Ramachandran K; Soloway MS; Singal R
    Int Braz J Urol; 2007; 33(1):11-8. PubMed ID: 17335593
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Epigenetic biomarkers in prostate cancer: Current and future uses.
    Chiam K; Ricciardelli C; Bianco-Miotto T
    Cancer Lett; 2014 Jan; 342(2):248-56. PubMed ID: 22391123
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Epigenetics in breast and prostate cancer.
    Wu Y; Sarkissyan M; Vadgama JV
    Methods Mol Biol; 2015; 1238():425-66. PubMed ID: 25421674
    [TBL] [Abstract][Full Text] [Related]  

  • 17. DNA methylation alterations exhibit intraindividual stability and interindividual heterogeneity in prostate cancer metastases.
    Aryee MJ; Liu W; Engelmann JC; Nuhn P; Gurel M; Haffner MC; Esopi D; Irizarry RA; Getzenberg RH; Nelson WG; Luo J; Xu J; Isaacs WB; Bova GS; Yegnasubramanian S
    Sci Transl Med; 2013 Jan; 5(169):169ra10. PubMed ID: 23345608
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Beyond the island: epigenetic biomarkers of colorectal and prostate cancer.
    Savio AJ; Bapat B
    Methods Mol Biol; 2015; 1238():103-24. PubMed ID: 25421657
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Epigenetic modulators as therapeutic targets in prostate cancer.
    Graça I; Pereira-Silva E; Henrique R; Packham G; Crabb SJ; Jerónimo C
    Clin Epigenetics; 2016; 8():98. PubMed ID: 27651838
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Diagnostic and prognostic epigenetic biomarkers in cancer.
    Costa-Pinheiro P; Montezuma D; Henrique R; Jerónimo C
    Epigenomics; 2015; 7(6):1003-15. PubMed ID: 26479312
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 18.